Report overview
Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin. This report contains market size and forecasts of Recombinant Human Serum Albumin in global, including the following market information:
Global Recombinant Human Serum Albumin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Recombinant Human Serum Albumin Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Recombinant Human Serum Albumin companies in 2022 (%)
The global Recombinant Human Serum Albumin market was valued at US$ 72 million in 2022 and is projected to reach US$ 114.7 million by 2029, at a CAGR of 7.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of recombinant human serum albumin include Albumedix, Merck, Ventria (InVitria), etc. The top three players hold a share about 88%. North America is the largest producer, holds a share around 46%, followed by Europe and China, with share 42% and 7%, separately. The largest market is North America, has a share about 59%, followed by Europe and China, with around 29% and 6% market share respectively.
We surveyed the Recombinant Human Serum Albumin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Serum Albumin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Type, 2022 (%)
OsrHSA
ScrHSA
Global Recombinant Human Serum Albumin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, by Application, 2022 (%)
Cell Culture Media
Medical Supplements
Others
Global Recombinant Human Serum Albumin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Recombinant Human Serum Albumin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Serum Albumin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Recombinant Human Serum Albumin revenues share in global market, 2022 (%)
Key companies Recombinant Human Serum Albumin sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Recombinant Human Serum Albumin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Albumedix
Merck
Ventria (InVitria)
NCPC
Oryzogen
HiMedia
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Serum Albumin, market overview.
Chapter 2: Global Recombinant Human Serum Albumin market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Serum Albumin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
